- Home
- SANG vs LXEO Comparison
SANG vs LXEO Comparison
Compare SANG & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SANG
- LXEO
- Stock Information
- Founded
- SANG 1984
- LXEO 2017
- Country
- SANG Canada
- LXEO United States
- Employees
- SANG N/A
- LXEO N/A
- Industry
- SANG Computer Software: Programming Data Processing
- LXEO
- Sector
- SANG Technology
- LXEO
- Exchange
- SANG Nasdaq
- LXEO Nasdaq
- Market Cap
- SANG 153.5M
- LXEO 140.6M
- IPO Year
- SANG 2021
- LXEO 2023
- Fundamental
- Price
- SANG $4.77
- LXEO $2.71
- Analyst Decision
- SANG
- LXEO Strong Buy
- Analyst Count
- SANG 0
- LXEO 5
- Target Price
- SANG N/A
- LXEO $22.20
- AVG Volume (30 Days)
- SANG 6.2K
- LXEO 1.4M
- Earning Date
- SANG 05-07-2025
- LXEO 05-08-2025
- Dividend Yield
- SANG N/A
- LXEO N/A
- EPS Growth
- SANG N/A
- LXEO N/A
- EPS
- SANG N/A
- LXEO N/A
- Revenue
- SANG $241,243,000.00
- LXEO N/A
- Revenue This Year
- SANG N/A
- LXEO N/A
- Revenue Next Year
- SANG $3.21
- LXEO N/A
- P/E Ratio
- SANG N/A
- LXEO N/A
- Revenue Growth
- SANG N/A
- LXEO N/A
- 52 Week Low
- SANG $4.04
- LXEO $1.45
- 52 Week High
- SANG $7.99
- LXEO $19.50
- Technical
- Relative Strength Index (RSI)
- SANG 51.88
- LXEO 48.48
- Support Level
- SANG $4.55
- LXEO $1.90
- Resistance Level
- SANG $4.76
- LXEO $2.64
- Average True Range (ATR)
- SANG 0.20
- LXEO 0.48
- MACD
- SANG 0.10
- LXEO 0.02
- Stochastic Oscillator
- SANG 89.61
- LXEO 51.43
About SANG Sangoma Technologies Corporation
Sangoma Technologies Corp is a provider of hardware and software components that enable or enhance Internet Protocol Communications Systems for both telecom and datacom applications. It is engaged in the development, manufacturing, distribution, and support of voice and data connectivity components for software-based communication applications. Its product includes data and telecom boards for media and signal processing, as well as gateway appliances and software. The Company sells into two geographic centers: USA and Other countries. Key revenue is generated from USA.
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a a clinical-stage genetic medicines company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated. Its pipeline consists of candidates targeting patient populations that place significant burden on society and are most amenable to their genetic medicine approach. The Company is focused on preclinical and clinical stage gene therapies, and specifically on hereditary and acquired diseases of high unmet need which is their only business segment.